Costs and Mortality Associated With Multidrug-Resistant Healthcare-Associated Acinetobacter Infections

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Infection Control & Hospital Epidemiology

• Publication date

  2016-07-13

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/ice.2016.145PMID 27406609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

  2017cited by this paper
• Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections

  2017cited by this paper
• Multidrug-Resistant Acinetobacter

  2017cited by this paper
• The Magnitude of Time-Dependent Bias in the Estimation of Excess Length of Stay Attributable to Healthcare-Associated Infections

  2015cited by this paper
• The Economic Impact of Clostridium difficile Infection: A Systematic Review

  2015cited by this paper
• Editorial commentary: the new Acinetobacter equation: hypervirulence plus antibiotic resistance equals big trouble.

  2015cited by this paper
• The Impact of Healthcare-Associated Methicillin-Resistant Staphylococcus Aureus Infections on Post-Discharge Healthcare Costs and Utilization

  2015cited by this paper
• Health care-associated methicillin-resistant Staphylococcus aureus infections increases the risk of postdischarge mortality.

  2015cited by this paper
• Fatal outbreak of an emerging clone of extensively drug-resistant Acinetobacter baumannii with enhanced virulence.

  2015cited by this paper
• Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.

  2014cited by this paper
• Antibiotic resistance threats in the United States: stepping back from the brink.

  2014cited by this paper
• Out-of-Pocket Spending in the Last Five Years of Life

  2013cited by this paper
• Trends in inpatient hospital deaths: National Hospital Discharge Survey, 2000-2010.

  2013influential reference
• Change in end-of-life care for Medicare beneficiaries: site of death, place of care, and health care transitions in 2000, 2005, and 2009.

  2013cited by this paper
• Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.

  2013cited by this paper
• Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial Stewardship

  2012influential reference
• Health care costs for patients with cancer at the end of life.

  2012cited by this paper
• Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration.

  2012influential reference
• Estimating the Proportion of Healthcare-Associated Infections That Are Reasonably Preventable and the Related Mortality and Costs

  2011cited by this paper
• Cost-of-Illness Studies

  2011cited by this paper
• Estimating the cost of health care-associated infections: mind your p's and q's.

  2010cited by this paper
• Long-term trends in Medicare payments in the last year of life.

  2010cited by this paper
• Trends in Antimicrobial Resistance of Acinetobacter baumannii Isolates from a Metropolitan Detroit Health System

  2010influential reference
• Multidrug Resistant Acinetobacter

  2010cited by this paper
• "Never events": not every hospital-acquired infection is preventable.

  2009influential reference
• Current control and treatment of multidrug-resistant Acinetobacter baumannii infections.

  2008cited by this paper
• Cost-of-illness studies in the United States: a systematic review of methodologies used for direct cost.

  2008cited by this paper
• Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization

  2007influential reference
• Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences.

  2007influential reference
• Attributable Mortality of Nosocomial Acinetobacter Bacteremia

  2007influential reference
• The epidemiology and control of Acinetobacter baumannii in health care facilities.

  2006influential reference
• Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital.

  2004influential reference
• Cost-of-illness analyses for policy making: a cautionary tale of use and misuse

  2003cited by this paper
• Multi-resistant Acinetobacter baumannii on a burns unit--clinical risk factors and prognosis.

  2002cited by this paper
• Citywide clonal outbreak of multiresistant Acinetobacter baumannii and Pseudomonas aeruginosa in Brooklyn, NY: the preantibiotic era has returned.

  2002cited by this paper
• Cost of illness studies: what is good about them?

  2000cited by this paper
• Evaluation of Acinetobacter baumannii Infection and Colonization, and Antimicrobial Treatment Patterns in an Urban Teaching Hospital

  1999influential reference
• Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features

  1996cited by this paper
• Cost-of-illness studies: fact or fiction?

  1994cited by this paper

• Genomic landscape of complete Acinetobacter phages: clustering, core-shell genes, and synteny insights

  2026cites this paper
• Outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections in intensive care units and prognostic effect of different antimicrobial regimens

  2025cites this paper
• Turning the Tide Against Carbapenem-resistant Acinetobacter baumannii: Advancing Care With Sulbactam–Durlobactam

  2025cites this paper
• Clinical and economic assessment of nosocomial pneumonia antibacterial therapy in Moscow hospital

  2025cites this paper
• Risk factors for bacteremic pneumonia and mortality (28-day mortality) in patients with Acinetobacter baumannii bacteremia

  2024cites this paper
• Evaluation of costs related to antimicrobial resistance of priority Gram-negative bacilli

  2024influential citation
• Genotypic and phenotypic mechanisms underlying antimicrobial resistance and synergistic efficacy of rifampicin-based combinations against carbapenem-resistant Acinetobacter baumannii

  2024cites this paper
• A novel system for removing examinee’s exhaled air using an open, lightweight non-sealing facemask-a proof-of-concept study

  2024cites this paper
• Retrospective analysis of Acinetobacter baumannii bacteraemia risk factors, complications and mortality in a tertiary university hospital in Saudi Arabia

  2024cites this paper
• Investigation of multiple nosocomial infections using a semi-Markov multi-state model

  2024cites this paper
• Clinical and molecular predictors of mortality in patients with carbapenem-resistant Acinetobacter baumannii bacteremia: A retrospective cohort study.

  2023cites this paper
• Contribution of active surveillance cultures to the control of hospital-acquired carbapenem-resistant Acinetobacter baumannii in an endemic hospital setting

  2023cites this paper
• The burden of carbapenem-resistant Enterobacterales infection in a large Thai tertiary care hospital

  2022cites this paper
• Comparison of pneumonia- and non-pneumonia-related Acinetobacter baumannii complex bacteremia: A single-center retrospective study.

  2022cites this paper
• Research on the economic loss of hospital-acquired pneumonia caused by Klebsiella pneumonia base on propensity score matching

  2021cites this paper
• Economic Burden Attributable to Healthcare-Associated Infections in Tertiary Public Hospitals of Central China: A Multi-Center Case-Control Study

  2021cites this paper
• Association between antibiotic resistance in intensive care unit (ICU)–acquired infections and excess resource utilization: Evidence from Spain, Italy, and Portugal

  2021cites this paper
• Multidrug-resistant Acinetobacter baumannii infections: looming threat in the Indian clinical setting

  2021cites this paper
• Economic burden attributable to healthcare-associated infections in tertiary public hospitals of Central China: a multi-centre case-control study

  2021cites this paper
• Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis

  2020cites this paper
• Characterizing the response of Acinetobacter baumannii ATCC 17978 to azithromycin in multiple in vitro growth conditions

  2020cites this paper
• Acinetobacter: An Enemy after Head and Neck Cancer Operations with Microvascular Free Flap Reconstruction?

  2020cites this paper
• Antimicrobial profile of Acinetobacter baumannii at a tertiary hospital in Honduras: a cross-sectional analysis

  2020cites this paper
• Epidemiology and clinical outcomes associated with extensively drug-resistant (XDR) Acinetobacter in US Veterans’ Affairs (VA) medical centers

  2020cites this paper
• Clinical and Microbiological Analysis of Risk Factors for Mortality in Patients With Carbapenem-Resistant Acinetobacter baumannii Bacteremia

  2020cites this paper
• Antibiotic‐Free Cationic Dendritic Hydrogels as Surgical‐Site‐Infection‐Inhibiting Coatings

  2019cites this paper
• Mechanisms of Action for Antimicrobial Peptides With Antibacterial and Antibiofilm Functions

  2019cites this paper
• Screening of promising molecules against MurG as drug target in multi-drug-resistant-Acinetobacter baumannii - insights from comparative protein modeling, molecular docking and molecular dynamics simulation

  2019cites this paper
• Effect of Chlorhexidine bathing on colonization or infection with Acinetobacter baumannii-a systematic review and meta-analysis.

  2019cites this paper
• Antibiotic Resistance: Origins, evolution and healthcare-associated infections

  2019cites this paper
• In Vitro and In Vivo Activity of a Novel Antisense Peptide Nucleic Acid Compound Against Multidrug-Resistant Acinetobacter baumannii

  2019cites this paper
• A 5-year surveillance on antimicrobial resistance of Acinetobacter isolates at a level-I trauma centre of India

  2019cites this paper
• The Slow-Motion Catastrophe of Antimicrobial Resistance and Practical Interventions for All Prescribers.

  2019cites this paper
• Understanding the Economic Impact of Health Care-Associated Infections: A Cost Perspective Analysis

  2019cites this paper
• Evaluation of a micro/nanofluidic chip platform for the high-throughput detection of bacteria and their antibiotic resistance genes in post-neurosurgical meningitis.

  2018cites this paper
• in the

  2017cites this paper
• Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

  2017cites this paper
• Anticipating the Unpredictable: A Review of Antimicrobial Stewardship and Acinetobacter Infections

  2017cites this paper
• Too Much Too Soon or Too Little Too Late: The Challenge of Preventing Acinetobacter Transmissions.

  2017cites this paper
• Emerging waves of carbapenem resistance among gram negative pathogens at a tertiary center

  2016cites this paper